IBSEN III
IBSEN III (IBSEN III - Inflammatory Bowel Disease in South Eastern Norway - Institute of Clinical Medicine (uio.no)) is an observational, prospective population-based inception cohort study, including patients at all 15 hospitals in the South Eastern Health Region (HSØ). In total 2254 IBD patients and controls were included between 2017 and 2019. Today, the five-year follow-up is ongoing, and the study has become one of the world largest treatment naïve, and population-based IBD cohorts. Importantly the study includes a very large biobank with biological materials sampled at time of diagnosis and prospectively at one and five years.
Thirteen ongoing PhD projects and one postdoc at seven hospitals in HSØ is a major asset for the IBD research environment not only at OUH but in the whole region. The PhD projects span from clinical epidemiology, PROM-research, dietary epidemiology, and health economy to cutting edge translational projects on microbiomics, proteomics and transcriptomics.
|
Project title |
PhD student |
Institution |
|
Changes in epidemiology and treatment strategies in IBD disease; implications for the health service and the social security services |
Charlotte Lund |
OUH, Dept. of Gastroenterology |
|
A new Norwegian population-based study in pediatric IBD |
Svend Andersen |
Vestfold Hospital, Dept of Pediatrics |
|
Clinical disease course in newly diagnosed IBD in the biological era |
Vibeke Strande |
Lovisenberg Hospital, Dept. of Gastroenterology |
|
Proteomics as diagnostic and prognostic biomarkers in IBD |
Charlotte Bache-Wiig Mathisen |
OUH, Dept. of Gastroenterology and Ørebro University Hospital |
|
Biomarkers of fibrosis in Crohn’s disease – prognostic and predictive potential |
Ida Glad |
Lovisenberg Hospital, Dept. of Gastroenterology and Nordic Bioscience |
|
Precision-MAID: Microbial Precision Medicine assisted by Artificial Intelligence in IBD |
Simen Hyll Hansen |
OUH, Rikshospitalet, Norwegian PSC Center |
|
Precision microbiome profiling in diagnosis and disease prediction in IBD |
Maria Maaseng |
OUH, Dept. of Gastroenterology, UiO and BioMe |
|
Spatial transcriptomics to predict treatment response in Crohn’s disease |
Karoline Rapp Vander-Elst |
OUH, Dept. of Pathology |
|
The missing heritability of IBD-a family study |
Tone Bergene Aabrekke |
Vestfold Hospital, Dept. of Gastroenterology |
|
Symptom burden in patients with IBD - impact on health-related quality of life and sick leave |
Ingunn Johannesen |
Østfold University College and Østfold Hospital, Dept. of Gastroenterologu |
|
Health-related quality of life during the first year with IBD |
Bjørn Olsen |
Telemark Hospital, Dept. of Gastroenterology |
|
Fatigue in IBD: Symptom course and prognostic factors the first year of diagnosis |
Kristina Holten |
Østfold Hospital, Dept. of Gastroenterology |
|
What did IBSEN eat? Diet in IBD |
Insaf Zerouga |
OUH, Dept. of nutrition |
IBSEN